缬沙坦与开博通联合应用治疗充血性心力衰竭(104例疗效观察)  

Treatment of Congestive Heart Failure with Combination of Valsartan and Captopril

作　　者：王明辉 任东伟 

机构地区：[1]呼伦贝尔市人民医院心内科,内蒙古呼伦贝尔021008

出　　处：《黑龙江医学》2007年第4期305-306,共2页Heilongjiang Medical Journal

摘　　要：目的观察缬沙坦与开博通联合治疗充血性心力衰竭的疗效。方法104例CHF患者的常规治疗的基础上,随机分成2组。对照组(A组)采用开博通治疗,治疗组(B组)采用缬沙坦与开博通治疗,均治疗4-6周。结果A组总有效率为82.69%,B组为96.15%,两组比较有统计学意义(P>0.05)。结论缬沙坦与开博通联合治疗CHF比单独使用开博通疗效更确切。Objective To observe the curative effect of congestive heart failure treated with combination of valsartan and catopril. Methods 104 cases of CHF patient were divided into two group on the routine therapy. Group A was treated with catopril and group B was treated with catopril andvalsartan for 4-6weeks. Results The total effective rate was 82.69% in group A and 96 .15 % ingroupBwithsigniflcantdifference. Conclusion There might be better for combination therapy with valsartan and catopril in the effect.

关 键 词：充血性的心力衰竭 血管紧张素Ⅱ受体AT1拮抗剂血管紧张素转换酶抑制剂 

分 类 号：R541.61[医药卫生—心血管疾病]